INTRAROSA

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Poland, Spain, UK.

Active ingredients

The drug INTRAROSA contains one active pharmaceutical ingredient (API):

1	Prasterone UNII 459AG36T1B - PRASTERONE
	Prasterone, i.e. dehydroepiandrosterone (DHEA), biochemically and biologically identical to the endogenous human DHEA, is a precursor steroid which is inactive by itself and it is converted into oestrogens and androgens. Intrarosa is thus different from the oestrogens preparations since it delivers also androgen metabolites.
	Read more about Prasterone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INTRAROSA Pessary	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A14AA07	Prasterone	A Alimentary tract and metabolism → A14 Anabolic agents for systemic use → A14A Anabolic steroids → A14AA Androstan derivatives
Discover more medicines within A14AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1765661
ES	Centro de información online de medicamentos de la AEMPS	1171255001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	098502
FR	Base de données publique des médicaments	60073960
GB	Medicines & Healthcare Products Regulatory Agency	369144
HK	Department of Health Drug Office	66651
IL	מִשְׂרַד הַבְּרִיאוּת	8626
IT	Agenzia del Farmaco	045933013
LT	Valstybinė vaistų kontrolės tarnyba	1085076
PL	Rejestru Produktów Leczniczych	100402008
US	FDA, National Drug Code	64011-601